Development and immunobiological evaluation of nanoparticles containing an immunodominant epitope of herpes simplex virus

Herpes simplex virus (HSV) 1 and 2 are viruses that infect individuals worldwide and for which there is no cure or vaccine available. The protective response against herpes is mostly mediated by CD8 T lymphocytes that respond to the immunodominant SSIEFARL epitope. However, there are some obstacles...

Descripción completa

Detalles Bibliográficos
Autores principales: Hilario, Gabriel M., Sulczewski, Fernando B., Liszbinski, Raquel, Mello, Larissa D., Hagen, Gustavo, Fazolo, Tiago, Neto, Jayme, Dallegrave, Eliane, Romão, Pedro, Aguirre, Tanira, Rodrigues Junior, Luiz C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675790/
https://www.ncbi.nlm.nih.gov/pubmed/34694744
http://dx.doi.org/10.1049/nbt2.12043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675790/
https://www.ncbi.nlm.nih.gov/pubmed/34694744
http://dx.doi.org/10.1049/nbt2.12043

Ejemplares similares